DOCSLIB.ORG

Vaccine Policy Brief 3/26

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vaccine Policy Brief 3/26 VACCINATE TEXAS THE SCIENCE OF VACCINES AND WHY THEY SHOULD BE A PRIORITY 2017 LEGISLATIVE SESSION !1 HEALTH POLICY BRIEF VACCINATE TEXAS The Science of Vaccines and Why They Should be a Priority—2017 Legislative Session Caitlin Comfort BA*, Maria Espinosa BS*, Rebecca Long Hetrick BA*, Claire Bocchini MD, MS *These authors contributed equally to the preparation of this manuscript Executive Summary As a result of widespread immunizations, the efficacy of vaccines in relation to common majority of Americans have never witnessed vaccine misconceptions. The latter half the devastating effects of diseases such as discusses the mounting dangers of falling polio, smallpox, pertussis, and measles. These vaccination rates in Texas and details policy achievements have led public health experts to proposals for the upcoming legislative commend vaccines as the greatest public session. health victory of our generation. However, despite the historical success of vaccines and We believe that the following proposals, modeled off the overwhelming body of scientific evidence of successful legislation enacted by other states, supporting them, myths and misinformation would advance the vaccine climate in Texas and regarding immunizations persist in Texas and throughout the United States. protect the health and safety of its citizens: Public health experts around the state have 1. Change the Texas Immunization Registry begun to issue warnings about the dangers (ImmTrac) to an Opt-Out System posed by rising vaccine exemption rates.25,27,76 Since non-medical exemptions were first 2. Empower families to make the best choices for allowed in Texas in 2003, the number of their child by releasing school-specific data on exemptions on file has increased 19-fold. vaccine exemption rates Recently, vaccine coverage in Texas has fallen well below national averages and this failure to 3. Require online education modules for parents or immunize has come at great cost. From 2005-2015, 100,000 Texans suffered from guardians seeking non-medical vaccine exemptions vaccine-preventable disease, resulting in over for their children 1,100 deaths.77 4. Invest in teaching health care providers how to To prevent more death and disease, state counter vaccine misinformation representatives should act quickly to improve immunization rates across the state. In support 5. Require the Texas Department of Health to publish of evidence-based decision making with an annual report on HPV immunization rates regards to immunizations, we have compiled the following policy brief. The first half of this 6. Neutralize the legal language surrounding vaccine brief explains the science and economics of vaccines. We also examine the safety and exemptions !2 HEALTH POLICY BRIEF Table of Contents Vaccines: The Most Successful Public Health Intervention………….…….…..4 The Importance of Herd Immunity……………………….….……….……5 Vaccines as a Cost-Effective Intervention…………………………………5 Vaccines: A Victim of Their Own Success……………………….………..6 Debunking Vaccine Myths………………………………………..…….………7 Vaccine Safety and Monitoring…………………………………………….7 The Current Vaccination Schedule and Effects on the Child’s Immune System……………………………………………..………….……..….…9 MMR and Autism: A Falsified Association………………….………….…10 Falling Vaccine Rates in Texas: A Time Bomb………………………..…..….…11 Policy Recommendations………………………………………………………12 1. Change Texas Immunization Registry to an Opt-Out System.……..…12 2. Release School-Specific Data on Vaccine Exemption Rates..….….…13 3. Require Online Education Modules for Non-Medical Vaccine Exemptions……………..…………………………………………….…..14 4. Invest in Teaching Healthcare Providers to Counter Vaccine Misinformation……………………………………..……………………..15 5. Require the Texas Department of Health to Publish an Annual Report on HPV Vaccination Rates………………………………………………..17 6. Neutralize the Legal Language Surrounding Vaccine Exemptions………………….………………………………………..…..18 References………………………………………………………..……..…..…19 !3 HEALTH POLICY BRIEF Vaccines: The Most Successful Public Health Intervention Vaccines prevent an estimated six million deaths per year globally.1 She was diagnosed with the flu and given They protect our bodies from infection by training the immune antibiotics. That night, Breanne’s fever system to recognize harmful germs more quickly. Essentially, persisted, rising to 107°F. B y t h e t i m e s h e vaccines work by mimicking an infection. However, unlike the was transported to an intensive care center, immunity acquired from an actual infection, vaccines do not cause the virus had already attacked Breanne’s illness.2,3 Vaccines introduce a substance into the body that heart and brain. Unable to survive the activates the immune system, producing disease-fighting blood extensive organ damage, Breanne succumbed cells and antibodies that last for years. to the flu shortly thereafter.6 After this tragedy, Breanne’s parents learned that ear infections While not all vaccine-preventable diseases seem serious, are not contraindications to common infections can lead to health complications and Between 2007 and receiving the flu vaccine. even death. For example, many Americans perceive 2015, 136 Texas Breanne’s parents believe that seasonal influenza or “the flu” as a mundane infection.4 children died from if their daughter had received However young children, older adults, and other 8 the vaccine, she would alive flu-related causes. individuals with weak immune systems can suffer today.6 devastating illness from the flu virus. This became a reality for two families who lost their children to the flu. Importantly, these tragic examples show how commonplace diseases can result in severe In 2004, the annual influenza vaccine was only recommended for illness and even death, leaving no doubt that children aged 6-23 months or for children with underlying chronic failing to immunize puts children at increased risk of harm. Following their losses, the Palmer medical conditions.5 Not fitting either of those categories, three- and Lastinger families became vocal year-old Emily Lastinger did not receive the flu shot that year. In advocates for flu vaccine awareness.7,10 January, Emily fell ill with the flu. After several days of antiviral medication and fluids, Emily’s parents found her lifeless and not breathing. Despite CPR and intensive medical intervention, Emily passed away. Autopsy reports indicated that Emily had died from PALMER FAMILY pus filling her lungs—a complication seen with severe influenza virus infections.6,7 Like the Lastingers, many families experienced losses under these previous immunization guidelines.7 Consequently, these guidelines were changed to advise that every child six months and older receive an annual flu vaccine.9 Similarly, in 2003 Breanne Palmer’s parents took her to the pediatrician for her annual flu shot. However, Breanne’s doctor found an infection in her ear and told the family to return for the vaccine later. Shortly thereafter, just days before Christmas, 15- month-old Breanne fell ill. When “Vaccines are simple her temperature rose to 101.5, and inexpensive tools to her parents returned to the pediatrician. protect kids. It’s the right thing to do, like PHOTO CREDIT: Kuntz, Paul Vincent., Kramer, Allen putting them in car S., Sinoris, George. Breanne Palmer Family, Emily Lastinger Family. 2010. Photograph. Vaccine- seats.” Preventable Disease: The Forgotten Story. Houston: Texas Children’s Hospital Center for Vaccine Awareness and Research, 2010. 26-27,34-35, – Father, Joe Lastinger 40-41. LASTINGER FAMILY !4 HEALTH POLICY BRIEF The Importance of Herd Immunity In addition to protecting the individual, vaccines protect communities from outbreaks of disease by creating herd immunity. Herd immunity occurs when a large majority of the community (the herd) is immunized, shielding the unvaccinated minority from disease. This phenomenon occurs because it is impossible for the disease to take hold when only few vulnerable individuals remain.11,12 The vaccine rate required to maintain herd immunity depends on the transmissibility of a particular disease. Most infections require immunization rates of 80-90% to maintain herd immunity. Highly contagious illnesses such as measles require 90-95% coverage.13,14 This means that when less than 90-95% of the population is immunized, diseases like measles have the potential to cause serious disease outbreaks. Furthermore, herd immunity protects individuals who cannot receive vaccines or be fully vaccinated. This group includes pregnant women, the elderly, newborns, and the immunocompromised. These individuals only remain safe through high vaccination rates in PHOTO CREDIT: Salanthe, Michael. “Herd immunity and their communities. Individuals with suppressed measles: Why We Should Aim For 100% Vaccination Coverage.” immune systems form a particularly vulnerable The Conversation, 2 Feb. 2015. Accessed 3 January 2017. population.15 This includes persons with inherited immunodeficiencies, immune suppressing infections, and individuals such as organ Vaccines as a Cost- transplant recipients on immune-suppressing therapies. Effective Intervention In Texas, vaccine-preventable diseases also constitute a significant economic burden. Data from the Texas Potentially Preventable Hospitalizations In 2014, an estimated 235 per Program provides some insight into the cost burden 100,000 Texas adults were of vaccine-preventable disease in our state. In 2014, an estimated 235 per 100,000 Texas adults were hospitalized for bacterial pneumonia. hospitalized for bacterial pneumonia.
Load more

Recommended publications
  • Summary of Supportive Science Regarding Thimerosal Removal
    Summary of Supportive Science Regarding Thimerosal Removal Updated December 2012 www.safeminds.org Science Summary on Mercury in Vaccines (Thimerosal Only) SafeMinds Update – December 2012 Contents ENVIRONMENTAL IMPACT ................................................................................................................................. 4 A PILOT SCALE EVALUATION OF REMOVAL OF MERCURY FROM PHARMACEUTICAL WASTEWATER USING GRANULAR ACTIVATED CARBON (CYR 2002) ................................................................................................................................................................. 4 BIODEGRADATION OF THIOMERSAL CONTAINING EFFLUENTS BY A MERCURY RESISTANT PSEUDOMONAS PUTIDA STRAIN (FORTUNATO 2005) ......................................................................................................................................................................... 4 USE OF ADSORPTION PROCESS TO REMOVE ORGANIC MERCURY THIMEROSAL FROM INDUSTRIAL PROCESS WASTEWATER (VELICU 2007)5 HUMAN & INFANT RESEARCH ............................................................................................................................ 5 IATROGENIC EXPOSURE TO MERCURY AFTER HEPATITIS B VACCINATION IN PRETERM INFANTS (STAJICH 2000) .................................. 5 MERCURY CONCENTRATIONS AND METABOLISM IN INFANTS RECEIVING VACCINES CONTAINING THIMEROSAL: A DESCRIPTIVE STUDY (PICHICHERO 2002) ......................................................................................................................................................
    [Show full text]
  • Pharmacovigilance in the European Union
    Michael Kaeding Julia Schmälter · Christoph Klika Pharmacovigilance in the European Union Practical Implementation across Member States Pharmacovigilance in the European Union Michael Kaeding · Julia Schmälter Christoph Klika Pharmacovigilance in the European Union Practical Implementation across Member States Prof. Dr. Michael Kaeding Julia Schmälter Christoph Klika Universität Duisburg-Essen Duisburg, Deutschland ISBN 978-3-658-17275-6 ISBN 978-3-658-17276-3 (eBook) DOI 10.1007/978-3-658-17276-3 Library of Congress Control Number: 2017932440 © The Editor(s) (if applicable) and The Author(s) 2017. This book is published open access. Open Access This book is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this book are included in the book's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the book’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
    [Show full text]
  • Stanford Health Policy Phd Handbook
    2016- 2017 STANFORD HEALTH A supplement to be used POLICY in conjunction with the Stanford Bulletin and the PHD Stanford Graduate Academic Policies and PROGRAM Procedures Handbook Stanford University School of Medicine STANFORD HEALTH POLICY PHD HANDBOOK Revised 11/2016. The department reserves the right to make changes at any time without prior notice. Stanford Health Policy PhD Handbook 2016-2017 CONTENTS INTRODUCTION ............................................................................................................................................. 3 PROGRAM DESCRIPTION........................................................................................................................... 3 PURPOSE OF THIS HANDBOOK ................................................................................................................. 4 STANFORD BULLETIN ................................................................................................................................ 4 GRADUATE ACADEMIC POLICIES AND PROCEDURES (GAP) ..................................................................... 4 PROGRAM INFORMATION ............................................................................................................................ 5 PROGRAM COMMITTEE, DIRECTORS & MANAGERS ................................................................................ 5 Program Director .................................................................................................................................. 5 Program Director
    [Show full text]
  • Supplemental Information and Guidance for Vaccination Providers Regarding Use of 9-Valent HPV Vaccine
    Supplemental information and guidance for vaccination providers regarding use of 9-valent HPV A 9-valent human papillomavirus (HPV) vaccine (9vHPV, Gardasil 9, Merck & Co.) was licensed for use in females and males in December 2014.1,2,3,4 The 9vHPV was the third HPV vaccine licensed in the United States by the Food and Drug Administration (FDA); the other vaccines are bivalent HPV vaccine (2vHPV, Cervarix, GlaxoSmithKline), licensed for use in females, and quadrivalent HPV vaccine (4vHPV, Gardasil, Merck & Co.), licensed for use in females and males.5 In February 2015, the Advisory Committee on Immunization Practices (ACIP) recommended 9vHPV as one of three HPV vaccines that can be used for routine vaccination of females and one of two HPV vaccines for routine vaccination of males.6 After the end of 2016, only 9vHPV will be distributed in the United States. In October 2016, ACIP updated HPV vaccination recommendations regarding dosing schedules.7 CDC now recommends two doses of HPV vaccine (0, 6–12 month schedule) for persons starting the vaccination series before the 15th birthday. Three doses of HPV vaccine (0, 1–2, 6 month schedule) continue to be recommended for persons starting the vaccination series on or after the 15th birthday and for persons with certain immunocompromising conditions. Guidance is needed for persons who started the series with 2vHPV or 4vHPV and may be completing the series with 9vHPV. The information below summarizes some of the recommendations included in ACIP Policy Notes and provides additional guidance.5-7 Information about the vaccines What are some of the similarities and differences between the three HPV vaccines? y Each of the three HPV vaccines is a noninfectious, virus-like particle (VLP) vaccine.
    [Show full text]
  • Pediatric Immunizations: Immunization Current Recommended Chedule and Ecommendations Immunization Schedule
    Online Continuing Education for Nurses Linking Learning to Performance INSIDE THIS COURSE PEDIATRIC IMMUNIZATIONS: IMMUNIZATION CURRENT RECOMMENDED SCHEDULE AND RECOMMENDATIONS IMMUNIZATION SCHEDULE ................ 1 ROUTINE IMMUNIZATIONS ............. 2 COMBINATION VACCINES .............. 6 2.27 Contact Hours VACCINATION ADMINISTRATION ......... 7 Written By: Erin Azuse, RN, BSN VACCINATION REACTIONS ................ 8 CONTRAINDICATIONS TO OBJECTIVES RECEIVING VACCINATIONS ............... 9 1. List the current recommended schedule of MISCONCEPTIONS ABOUT VACCINATIONS ................................ 9 immunizations per the CDC and discuss how the list is updated. THE FUTURE FOR PEDIATRIC IMMUNIZATIONS ............................. 10 2. Identify 10 preventable diseases for which REFERENCES ................................ 11 children routinely receive immunizations. CE EXAM...................................... 13 3. Discuss symptoms and complications of these EVALUATION ................................. 16 diseases. 4. Be familiar with combination vaccines and their components. 5. Explain the proper nursing procedure for administering vaccinations. 6. Identify the potential reactions that may occur from immunizations. 7. Describe any contraindications to receiving immunizations. 8. Identify common misconceptions about vaccinations and describe the nurse’s role in changing this. CURRENT RECOMMENDED IMMUNIZATION SCHEDULE The Centers for Disease Control and Prevention (CDC) recommends a schedule of routine vaccinations to protect against
    [Show full text]
  • Drug Policy 101: Pharmaceutical Marketing Tactics
    Institute for Health Policy Drug Policy 101: Pharmaceutical Marketing Tactics This brief describes the types of marketing tactics that pharmaceutical companies use and the adverse impacts those tactics can have on patients, clinicians, and the health care system. Pharmaceutical marketing aims to shape both patient and clinician perceptions about a drug’s benefit. However, prescription drugs are not typical consumer products. Patients rely heavily on conversations with and advice from clinicians to make decisions, including when faced with choices about whether and which drugs are appropriate treatment options. In addition, patients often do not know the true cost of a prescription drug as it is often subsidized by insurance. Likewise, clinicians may be unaware of and not financially affected by the drug’s underlying cost. Therefore, they might not take into account considerable disparities in price between different, but comparably effective, options for patients. As a result, both patients and clinicians are often insulated from the direct financial impact of selecting a higher-priced product. Due to these dynamics, pharmaceutical marketing can significantly impact patient and clinician decisions that then greatly affect outcomes, in addition to draining government and health care Pharmaceutical companies spend billions system resources. on marketing $20.3B Marketing tactics can drive overprescribing through higher doses and longer courses of treatment than are necessary, as well as overuse $15.6B of newer, higher-priced drugs instead
    [Show full text]
  • Vaccine Hesitancy
    WHY CHILDREN WORKSHOP ON IMMUNIZATIONS ARE NOT VACCINATED? VACCINE HESITANCY José Esparza MD, PhD - Adjunct Professor, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA - Robert Koch Fellow, Robert Koch Institute, Berlin, Germany - Senior Advisor, Global Virus Network, Baltimore, MD, USA. Formerly: - Bill & Melinda Gates Foundation, Seattle, WA, USA - World Health Organization, Geneva, Switzerland The value of vaccination “The impact of vaccination on the health of the world’s people is hard to exaggerate. With the exception of safe water, no other modality has had such a major effect on mortality reduction and population growth” Stanley Plotkin (2013) VACCINES VAILABLE TO PROTECT AGAINST MORE DISEASES (US) BASIC VACCINES RECOMMENDED BY WHO For all: BCG, hepatitis B, polio, DTP, Hib, Pneumococcal (conjugated), rotavirus, measles, rubella, HPV. For certain regions: Japanese encephalitis, yellow fever, tick-borne encephalitis. For some high-risk populations: typhoid, cholera, meningococcal, hepatitis A, rabies. For certain immunization programs: mumps, influenza Vaccines save millions of lives annually, worldwide WHAT THE WORLD HAS ACHIEVED: 40 YEARS OF INCREASING REACH OF BASIC VACCINES “Bill Gates Chart” 17 M GAVI 5.6 M 4.2 M Today (ca 2015): <5% of children in GAVI countries fully immunised with the 11 WHO- recommended vaccines Seth Berkley (GAVI) The goal: 50% of children in GAVI countries fully immunised by 2020 Seth Berkley (GAVI) The current world immunization efforts are achieving: • Equity between high and low-income countries • Bringing the power of vaccines to even the world’s poorest countries • Reducing morbidity and mortality in developing countries • Eliminating and eradicating disease WHY CHILDREN ARE NOT VACCINATED? •Vaccines are not available •Deficient health care systems •Poverty •Vaccine hesitancy (reticencia a la vacunacion) VACCINE HESITANCE: WHO DEFINITION “Vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite availability of vaccination services.
    [Show full text]
  • Eugenics and Domestic Science in the 1924 Sociological Survey of White Women in North Queensland
    This file is part of the following reference: Colclough, Gillian (2008) The measure of the woman : eugenics and domestic science in the 1924 sociological survey of white women in North Queensland. PhD thesis, James Cook University. Access to this file is available from: http://eprints.jcu.edu.au/5266 THE MEASURE OF THE WOMAN: EUGENICS AND DOMESTIC SCIENCE IN THE 1924 SOCIOLOGICAL SURVEY OF WHITE WOMEN IN NORTH QUEENSLAND Thesis submitted by Gillian Beth COLCLOUGH, BA (Hons) WA on February 11 2008 for the degree of Doctor of Philosophy in the School of Arts and Social Sciences James Cook University Abstract This thesis considers experiences of white women in Queensland‟s north in the early years of „white‟ Australia, in this case from Federation until the late 1920s. Because of government and health authority interest in determining issues that might influence the health and well-being of white northern women, and hence their families and a future white labour force, in 1924 the Institute of Tropical Medicine conducted a comprehensive Sociological Survey of White Women in selected northern towns. Designed to address and resolve concerns of government and medical authorities with anxieties about sanitation, hygiene and eugenic wellbeing, the Survey used domestic science criteria to measure the health knowledge of its subjects: in so doing, it gathered detailed information about their lives. Guided by the Survey assessment categories, together with local and overseas literature on racial ideas, the thesis examines salient social and scientific concerns about white women in Queensland‟s tropical north and in white-dominated societies elsewhere and considers them against the oral reminiscences of women who recalled their lives in the North for the North Queensland Oral History Project.
    [Show full text]
  • Hepatitis B Vaccination Schedule and PVS Guidance for Infants Born to Hepatitis B Positive Women
    Hepatitis B Vaccination Schedule and PVS Guidance for Infants Born to Hepatitis B Positive Women Pediatric Hepatitis B Vaccination Schedule and Product Options Following the birth dose of hepatitis B vaccine and HBIG, the infant needs either two doses of monovalent hepatitis B vaccine or three doses of a hepatitis B-containing combination vaccine to complete the hepatitis B vaccine series. In particular, please note: . Pediarix should not be administered before 6 weeks of age. The final dose of hepatitis B vaccine (either the third or fourth dose) should be given on or after 6 months of age. Do not give it before 24 weeks of age. Comvax is not approved for use in infants born to hepatitis B positive women OPTION 1: Monovalent hepatitis B vaccine schedule (Energix or Recombivax) Dose Timing Dose 1 (given with HBIG) Within 12 hours after birth Dose 2 1-2 months of age Dose 3 6 months of age Post-vaccination serology (HBsAg and anti-HBs) 1-2 months after last dose, but not before 9 months of age OPTION 2: Pediarix vaccine schedule Dose Timing Dose of monovalent hep B vaccine (given with HBIG) Within 12 hours after birth Dose 2 6 weeks to 2 months of age (do not administer before 6 weeks of age) Dose 3 4 months of age Dose 4 6 months of age Post-vaccination serology (HBsAg and anti-HBs) 1-2 months after last dose, but not before 9 months of age Post-vaccination Serology (PVS) Results and Recommended Follow-up Serology result Follow-up needed HBsAg negative None.
    [Show full text]
  • National Prevention Strategy AMERICA’S PLAN for BETTER HEALTH and WELLNESS
    National Prevention Strategy AMERICA’S PLAN FOR BETTER HEALTH AND WELLNESS June 2011 National Prevention, Health Promotion and Public Health Council For more information about the National Prevention Strategy, go to: http://www.healthcare.gov/center/councils/nphpphc. OFFICE of the SURGEON GENERAL 5600 Fishers Lane Room 18-66 Rockville, MD 20857 email: [email protected] Suggested citation: National Prevention Council, National Prevention Strategy, Washington, DC: U.S. Department of Health and Human Services, Office of the Surgeon General, 2011. National Prevention Strategy America’s Plan for Better Health and Wellness June 16, 2011 2 National Prevention Message from the Chair of the National Prevention,Strategy Health Promotion, and Public Health Council As U.S. Surgeon General and Chair of the National Prevention, Health Promotion, and Public Health Council (National Prevention Council), I am honored to present the nation’s first ever National Prevention and Health Promotion Strategy (National Prevention Strategy). This strategy is a critical component of the Affordable Care Act, and it provides an opportunity for us to become a more healthy and fit nation. The National Prevention Council comprises 17 heads of departments, agencies, and offices across the Federal government who are committed to promoting prevention and wellness. The Council provides the leadership necessary to engage not only the federal government but a diverse array of stakeholders, from state and local policy makers, to business leaders, to individuals, their families and communities, to champion the policies and programs needed to ensure the health of Americans prospers. With guidance from the public and the Advisory Group on Prevention, Health Promotion, and Integrative and Public Health, the National Prevention Council developed this Strategy.
    [Show full text]
  • Recommended Adult Immunization Schedule
    Recommended Adult Immunization Schedule UNITED STATES for ages 19 years or older 2021 Recommended by the Advisory Committee on Immunization Practices How to use the adult immunization schedule (www.cdc.gov/vaccines/acip) and approved by the Centers for Disease Determine recommended Assess need for additional Review vaccine types, Control and Prevention (www.cdc.gov), American College of Physicians 1 vaccinations by age 2 recommended vaccinations 3 frequencies, and intervals (www.acponline.org), American Academy of Family Physicians (www.aafp. (Table 1) by medical condition and and considerations for org), American College of Obstetricians and Gynecologists (www.acog.org), other indications (Table 2) special situations (Notes) American College of Nurse-Midwives (www.midwife.org), and American Academy of Physician Assistants (www.aapa.org). Vaccines in the Adult Immunization Schedule* Report y Vaccines Abbreviations Trade names Suspected cases of reportable vaccine-preventable diseases or outbreaks to the local or state health department Haemophilus influenzae type b vaccine Hib ActHIB® y Clinically significant postvaccination reactions to the Vaccine Adverse Event Hiberix® Reporting System at www.vaers.hhs.gov or 800-822-7967 PedvaxHIB® Hepatitis A vaccine HepA Havrix® Injury claims Vaqta® All vaccines included in the adult immunization schedule except pneumococcal 23-valent polysaccharide (PPSV23) and zoster (RZV) vaccines are covered by the Hepatitis A and hepatitis B vaccine HepA-HepB Twinrix® Vaccine Injury Compensation Program. Information on how to file a vaccine injury Hepatitis B vaccine HepB Engerix-B® claim is available at www.hrsa.gov/vaccinecompensation. Recombivax HB® Heplisav-B® Questions or comments Contact www.cdc.gov/cdc-info or 800-CDC-INFO (800-232-4636), in English or Human papillomavirus vaccine HPV Gardasil 9® Spanish, 8 a.m.–8 p.m.
    [Show full text]
  • A Systematic Review of Key Issues in Public Health 1St Edition Pdf, Epub, Ebook
    A SYSTEMATIC REVIEW OF KEY ISSUES IN PUBLIC HEALTH 1ST EDITION PDF, EPUB, EBOOK Stefania Boccia | 9783319374826 | | | | | A Systematic Review of Key Issues in Public Health 1st edition PDF Book Immigrants and refugees of al There are claims that energy drink ED consumption can bring about an improvement in mental functioning in the form of increased alertness and enhanced mental and physical energy. Urbanization: a problem for the rich and the poor? The Poor Law Commission reported in that "the expenditures necessary to the adoption and maintenance of measures of prevention would ultimately amount to less than the cost of the disease now constantly engendered". They could also choose sites they considered salubrious for their members and sometimes had them modified. Berridge, Virginia. Rigby, Caroline J. Urban History. Reforms included latrinization, the building of sewers , the regular collection of garbage followed by incineration or disposal in a landfill , the provision of clean water and the draining of standing water to prevent the breeding of mosquitoes. Environmental health Industrial engineering Occupational health nursing Occupational health psychology Occupational medicine Occupational therapist Safety engineering. An inherent feature of drug control in many countries has been an excessive emphasis on punitive measures at the expense of public health. Once it became understood that these strategies would require community-wide participation, disease control began being viewed as a public responsibility. The upstream drivers
    [Show full text]